Cart
sales@molnova.com
CXCL-CXCR1/2-IN-1
CAS No. 2415653-55-1
CXCL-CXCR1/2-IN-1( —— )
Catalog No. M37526 CAS No. 2415653-55-1
CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 198 | In Stock |
|
| 100MG | 296 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 706 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCXCL-CXCR1/2-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.
-
DescriptionCXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCXCR
-
RecptorCXCR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2415653-55-1
-
Formula Weight383.21
-
Molecular FormulaC14H8Cl2N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC(Cl)=CC(Cl)=C1)NC2=NC3=C(S2)C=C([N+]([O-])=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Syringaresinol-di-O-...
1. Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.
-
VUF11207 fumarate
VUF11207 fumarate is an agonist of CXCR7 and a high-potency ligand of CXCR7 (pKi: 8.1).
-
Ulocuplumab
Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and multiple myeloma transplantation models.
